Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Towers Regulatory News (HTWS)

Share Price Information for Helios Towers (HTWS)

Share Price is delayed by 15 minutes
Get Live Data
222.60    0.00 (0.00%)
Bid:
222.40
Ask:
222.80
Spread: 0.40 (0.18%)
Market Cap: £2.27b
HTWS Live PriceLast checked at - London Stock Exchange

Intraday Helios Towers Share Chart

Helios Towers_TR1_Notification FCA Submitted

15 Sep 2025 14:36

RNS Number : 3846Z
Helios Towers PLC
15 September 2025
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BJVQC708

Issuer Name

HELIOS TOWERS PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of financial instruments

3. Details of person subject to the notification obligation

Name

Helikon Investments Limited

City of registered office (if applicable)

London

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Name

City of registered office

Country of registered office

Helikon Long Short Equity Fund Master ICAV

Dublin

Ireland

5. Date on which the threshold was crossed or reached

28-May-2025

6. Date on which Issuer notified

15-September-2025

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

0.000000

12.074700

12.074700

127448278

Position of previous notification (if applicable)

0.000000

11.068027

11.068027

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

 

Sub Total 8.A

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Cash Settled Equity Swap

28/02/2035

28/02/2035

Cash

18217463

1.726000

Cash Settled Equity Swap

17/11/2025

17/11/2025

Cash

5767516

0.546400

Cash Settled Equity Swap

16/11/2027

16/11/2027

Cash

44275240

4.194700

Cash Settled Equity Swap

16/11/2027

16/11/2027

Cash

10750367

1.018500

Cash Settled Equity Swap

30/06/2026

30/06/2026

Cash

48437692

4.589100

Sub Total 8.B2

127448278

12.074700%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Helikon Long Short Equity Fund Master ICAV

Helikon Long Short Equity Fund Master ICAV

12.074700

12.074700%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

29-May-2025

13. Place Of Completion

London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUVUORVBUKAAR
Date   Source Headline
6th Oct 20259:15 amRNSHolding(s) in Company
3rd Oct 20257:04 amRNSHolding(s) in Company
1st Oct 20257:00 amRNSResults of convertible bond tender
30th Sep 20255:27 pmRNSLaunch of convertible bond tender
19th Sep 20252:56 pmRNSDirector/PDMR Shareholding
18th Sep 20259:34 amRNSHolding(s) in Company
15th Sep 20252:36 pmRNSHelios Towers_TR1_Notification FCA Submitted
11th Sep 20257:00 amRNSAppointment of Corporate Broker
21st Aug 202511:17 amRNSDirector Declaration
31st Jul 20257:00 amRNSH1 2025 Results
3rd Jul 20257:00 amRNSNotice of H1 2025 Results Date & Conference Call
1st Jul 20259:41 amRNSHolding(s) in Company
1st Jul 20257:00 amRNSBlock Listing Application
23rd Jun 20251:27 pmRNSHolding(s) in Company
18th Jun 20251:16 pmRNSDirector/PDMR Shareholding
16th May 20257:00 amRNSChange of Director Responsibilities
15th May 20253:32 pmRNS2025 Annual General Meeting Results
9th May 20254:35 pmRNSHolding(s) in Company
8th May 20257:00 amRNSQ1 2025 Results
6th May 20258:30 amRNSBlock Listing Six Monthly Return
9th Apr 20257:00 amRNSNotice of Q1 2025 Results Date & Conference Call
8th Apr 20258:36 amRNSHolding(s) in Company
8th Apr 20258:32 amRNSHolding(s) in Company
7th Apr 202510:18 amRNSAnnual Report and Notice of AGM
31st Mar 20259:45 amRNSTotal Voting Rights
28th Mar 20256:19 pmRNSHolding(s) in Company
17th Mar 20251:21 pmRNSDirector/PDMR Shareholding
14th Mar 20254:36 pmRNSNotification of Major Holdings
4th Feb 20259:18 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSNotice of FY 2024 Results Date & Conference Call
8th Jan 20257:00 amRNSHolding(s) in Company
6th Jan 20252:33 pmRNSChange to a Director’s Role and Responsibilities
19th Dec 202410:53 amRNSDirector/PDMR Shareholding
9th Dec 202411:02 amRNSDirector/PDMR Shareholding
26th Nov 20249:09 amRNSHolding(s) in Company
22nd Nov 20247:00 amRNSHolding(s) in Company
20th Nov 202410:07 amRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSRESULTS OF SECONDARY PLACING OF HELIOS TOWERS PLC
19th Nov 20244:47 pmRNSPROPOSED SECONDARY PLACING IN HELIOS TOWERS PLC
19th Nov 20243:40 pmRNSHolding(s) in Company
7th Nov 20247:00 amRNSQ3 2024 Results
4th Nov 20247:00 amRNSBlock Listing Six Monthly Return
8th Oct 20247:00 amRNSNotice of Q3 2024 Results Date & Conference Call
30th Sep 20241:04 pmRNSHolding(s) in Company
16th Sep 20247:00 amRNSAppointment of Non-Executive Director
8th Aug 20247:00 amRNSHalf-year Report
3rd Jul 20247:00 amRNSNotice of H1 2024 Results Date & Conference Call
20th Jun 20246:02 pmRNSHolding(s) in Company
20th Jun 20243:24 pmRNSDirector/PDMR Shareholding
19th Jun 20245:44 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.